69 results
Page 2 of 4
8-K
EX-99.1
v36c0jg hd9
6 Oct 22
Motus GI Granted a U.S. Patent for Prepless Colonoscopy Methods
9:15am
8-K
EX-99.1
uqmvv7 u48
29 Sep 22
Regulation FD Disclosure
9:15am
8-K
EX-99.1
d041v prly2s
11 Aug 22
Motus GI Reports Second Quarter 2022 Financial Results
4:10pm
8-K
EX-99.1
z5gqhxri4w4e53is7
11 Aug 22
Other Events
8:05am
8-K
EX-99.1
6nv6ru
24 May 22
Motus GI Announces Positive Topline Data From EU Study of the Pure-Vu System
4:10pm
8-K
EX-99.1
rt88v0yluphu4 f8wpv
12 May 22
Motus GI Reports First Quarter 2022 Financial Results
4:10pm
8-K
EX-99.1
jdh8it
21 Apr 22
Regulation FD Disclosure
8:05am
8-K
EX-99.1
308mpsky90m 9y0lo0
29 Mar 22
Motus GI Reports Fourth Quarter and Full Year 2021 Financial Results
4:05pm
8-K
EX-99.1
dqn9yvsz trjn8lh6wrd
24 Feb 22
Motus GI Granted 180-Day Extension to Meet NASDAQ Minimum Bid Price Requirement
8:10am
8-K
EX-99.1
4om8g1dq09 3hh9
14 Feb 22
Motus GI Receives FDA Clearance to Market the Pure-Vu® EVS System
6:40am
8-K
EX-99.1
hch9faaa4kz
16 Dec 21
Motus GI Announces U.S. Patent For The Pure-Vu® System's Automatic Self-Purging Features
8:40am
8-K
EX-99.1
lrpzya
12 Nov 21
Motus GI Reports Third Quarter 2021 Financial Results and Provides Corporate Update
8:07am
8-K
EX-99.1
clw4dujhnv2jheqt6og5
26 Oct 21
Motus GI Announces Presentation of Results from Independent Study of Pure-Vu System in IBP Patients at the 2021 ACG Annual Scientific Meeting
8:12am
8-K
EX-99.1
nba3by4b9z4r2rrgb3i
8 Sep 21
Motus GI Announces Enrollment of Patients at Second Site in the European Union
8:16am